Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Dabigatran and warfarin are oral anticoagulant drugs widely used for the prevention of stroke in patients with atrial fibrillation. The objective of this study was to evaluate the interaction between aging and dabigatran- and warfarin-induced gastrointestinal (GI) and nervous system hemorrhage using data available in the FDA Adverse Event Reporting System (FAERS) database. | Evaluation of dabigatran and warfarin associated hemorrhagic events using the FDA adverse event reporting system database stratified by age
